Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine
- PMID: 34367381
- PMCID: PMC8334338
- DOI: 10.1007/s13167-021-00248-z
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine
Abstract
Endothelin-1 (ET-1) is involved in the regulation of a myriad of processes highly relevant for physical and mental well-being; female and male health; in the modulation of senses, pain, stress reactions and drug sensitivity as well as healing processes, amongst others. Shifted ET-1 homeostasis may influence and predict the development and progression of suboptimal health conditions, metabolic impairments with cascading complications, ageing and related pathologies, cardiovascular diseases, neurodegenerative pathologies, aggressive malignancies, modulating, therefore, individual outcomes of both non-communicable and infectious diseases such as COVID-19. This article provides an in-depth analysis of the involvement of ET-1 and related regulatory pathways in physiological and pathophysiological processes and estimates its capacity as a predictor of ageing and related pathologies,a sensor of lifestyle quality and progression of suboptimal health conditions to diseases for their targeted preventionand as a potent target for cost-effective treatments tailored to the person.
Keywords: Ageing; COVID-19; Cancer; Cardiovascular disease; Drug sensitivity; ET-1; Embryonic development; Endothelin; Endothelin axis; Female and male health; Individual outcomes; Lifestyle; Mental health; Metabolic impairments; Neurodegeneration; Nitric oxide; Pain sensitivity; Predictive preventive personalised medicine (PPPM/3PM); Pregnancy; Sense regulation; Stress reaction; Stroke; Suboptimal health; Treatment target; Vasoconstriction; Vasodilation; Vasospasm; Wound healing.
© The Author(s) 2021.
Conflict of interest statement
Conflict of interestThe authors declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8417197/bin/13167_2021_248_Fig1a_HTML.gif)
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8417197/bin/13167_2021_248_Fig1a_HTML.gif)
Similar articles
-
Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.EPMA J. 2024 Apr 8;15(2):289-319. doi: 10.1007/s13167-024-00357-5. eCollection 2024 Jun. EPMA J. 2024. PMID: 38841622 Free PMC article. Review.
-
All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.EPMA J. 2021 Sep 13;12(4):403-433. doi: 10.1007/s13167-021-00253-2. eCollection 2021 Dec. EPMA J. 2021. PMID: 34539937 Free PMC article.
-
Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.EPMA J. 2021 Aug 17;12(3):243-264. doi: 10.1007/s13167-021-00251-4. eCollection 2021 Sep. EPMA J. 2021. PMID: 34422142 Free PMC article.
-
Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive and personalised (3P) medicine.EPMA J. 2021 Aug 6;12(3):349-363. doi: 10.1007/s13167-021-00250-5. eCollection 2021 Sep. EPMA J. 2021. PMID: 34377218 Free PMC article.
-
Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine.EPMA J. 2021 Mar 4;12(1):27-40. doi: 10.1007/s13167-021-00237-2. eCollection 2021 Mar. EPMA J. 2021. PMID: 33686350 Free PMC article. Review.
Cited by
-
The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.EPMA J. 2024 Feb 27;15(1):1-23. doi: 10.1007/s13167-024-00356-6. eCollection 2024 Mar. EPMA J. 2024. PMID: 38463624 Free PMC article.
-
The mediating effect of perceived stress on the relationship between big five personality traits and suboptimal health status in Chinese population: a nationwide survey in the framework of predictive, preventive, and personalized medicine.EPMA J. 2023 Dec 11;15(1):25-38. doi: 10.1007/s13167-023-00349-x. eCollection 2024 Mar. EPMA J. 2023. PMID: 38463623
-
Emerging frontiers of artificial intelligence and machine learning in ischemic stroke: a comprehensive investigation of state-of-the-art methodologies, clinical applications, and unraveling challenges.EPMA J. 2023 Nov 2;14(4):645-661. doi: 10.1007/s13167-023-00343-3. eCollection 2023 Dec. EPMA J. 2023. PMID: 38094579 Review.
-
Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes.EPMA J. 2023 Dec 6;14(4):673-696. doi: 10.1007/s13167-023-00348-y. eCollection 2023 Dec. EPMA J. 2023. PMID: 38094577 Review.
-
Endothelin-1: Is it Time to "Biomark" the Cardiac-Tumor-Treatment Nexus in Breast Cancer?JACC CardioOncol. 2023 Oct 17;5(5):701-703. doi: 10.1016/j.jaccao.2023.05.007. eCollection 2023 Oct. JACC CardioOncol. 2023. PMID: 37969651 Free PMC article.
References
-
- Zhang H, Cao Y, Pei H, Wang H, Ma L, Wang Z, Diao X, Yang Y, Liu N, Wei Y, et al. Shenmayizhi formula combined with Ginkgo extract tablets for the treatment of vascular dementia: a randomized, double-blind, controlled trial. Evid Based Complement Alternat Med. 2020;2020:8312347. doi: 10.1155/2020/8312347. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources